1. Aligning Policy Agendas The case of personalised care and cure for healthy and active ageing Setting the scene for the DG Regio and Flanders Smart Specialisation Conference Brussels, 8 November 2013 Dr Patries Boekholt

2. Healthy Ageing: a key societal challenge Needs little further introduction -> high on many policy agendas Addresses societal challenges and offers opportunities (driver for innovations and economic growth) Healthy Ageing is a topic in multiple policy domains Health Policy Social Policy Research and Innovation Policy Industrial Policy ICT Policy … and also in Smart Specialisation Strategies Policy approaches not joined up 2

3. Personalised care & cure as driver for innovations impacts on patients and their families -> societal perspective impacts on business and business models -> economic perspective impacts on the health care systems -> organisational and finance perspectives 3 Personalised cure Personalised care

4. Innovations too big for one actor to handle…. Tackling the bottlenecks in both cure and care asks for systemic changes and solutions Personalised cure asks for different care models Reconsidering health economics Large scientific and technological challenges Technological breakthroughs not the only issue -> organisational and economic bottlenecks as important The business sector is reluctant to invest in new personalised cure concepts The regulatory frameworks need to be adapted to personalised cure Data protection and ethical issues Adaptation of reimbursement systems 4

5. Early diagnosis Assisted daily living Prevention chronic diseases Independent living Social interaction of elderly people Self management of daily life Interoperationability for eHealth Personalised medicines Distant patient monitoring Integrated care systems European Innovation Partnership AHA Health for Growth Ambient Assisted Living Digital Agenda for Europe Horizon 2020 Health, Demographic Change and Wellbeing Horizon 2020 Health, Demographic Change and Wellbeing Innovative Medicine Initiative Biomarkers EU legislation cross border healthcare

6. Good and bad news from the regional front Many regions have chosen Health as one of their key priorities in their smart specialisation strategies Increasing awareness and political support A wide diversity of stakeholders involved BUT …, Strategies are not aligned with each other -> failing to benefit from the leverage and synergy of existing initiatives and roadmaps Many small scale initiatives No European mind-set while developing strategies -> what specific competences do we have to offer? 6

7. Are we using Europe’s full potential? We risk unnecessary duplication and fragmentation The lessons from small scale pilots and trials could be disseminated more widely and quickly Information sharing Trusting each other’s evidence Innovations that have proven to work could be scaled up To increase societal impact To increase economic impact -> in the global market We achieve incremental innovations, but the systemic issues in the health care systems of Europe are not tackled In the expensive and high risk personalised cure we might fail to support excellence 7

8. Possible next steps (1) Mapping of programmes and initiatives Development of a common vocabulary Sharing of good practices and policy learning Provide policy programming platforms to help national, regional and local governments with matching up and coordination of local strategies (e.g. joint programming for regions) Ensuring of interoperationability of solutions Exploring the scaling up regional and local initiatives (test-beds, living labs, new care concepts) to develop common European standards and reaping the opportunities of an internal European healthy ageing market 8

9. Possible next steps (2) Removing regulatory barriers and developing clear, consistent and predictable regulatory and reimbursement pathways Supporting cross-border clinical trials and bioinformatics infrastructures to support the research for personalised cures Developing big-data solutions for eHealth …. and many others that we could discuss today 9

10. Key questions for today… Do we have strong common goals and clear enough shared objectives? Do current European and regional strategies suffice to align national and regional partnerships? In which domains/areas do we see a mismatch (missing links, overlaps, etc.)? What can be done, starting tomorrow, on the various levels (European, national, regional) to support this differentiation/alignment process? 10

11. 11 Thank you technopolis |group| has offices in Amsterdam, Ankara, Brighton, Brussels, Frankfurt/Main, Paris, Stockholm, Tallinn and Vienna